Garcia-Vidal, E.; Calba, I.; Riveira-Muñoz, E.; GarcÃa, E.; Clotet, B.; Serra-Mitjà , P.; Cabrera, C.; Ballana, E.; Badia, R.
Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response. Int. J. Mol. Sci. 2024, 25, 5318.
https://doi.org/10.3390/ijms25105318
AMA Style
Garcia-Vidal E, Calba I, Riveira-Muñoz E, GarcÃa E, Clotet B, Serra-Mitjà P, Cabrera C, Ballana E, Badia R.
Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response. International Journal of Molecular Sciences. 2024; 25(10):5318.
https://doi.org/10.3390/ijms25105318
Chicago/Turabian Style
Garcia-Vidal, Edurne, Ignasi Calba, Eva Riveira-Muñoz, Elisabet GarcÃa, Bonaventura Clotet, Pere Serra-Mitjà , Cecilia Cabrera, Ester Ballana, and Roger Badia.
2024. "Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response" International Journal of Molecular Sciences 25, no. 10: 5318.
https://doi.org/10.3390/ijms25105318
APA Style
Garcia-Vidal, E., Calba, I., Riveira-Muñoz, E., GarcÃa, E., Clotet, B., Serra-Mitjà , P., Cabrera, C., Ballana, E., & Badia, R.
(2024). Nucleotide-Binding Oligomerization Domain 1 (NOD1) Agonists Prevent SARS-CoV-2 Infection in Human Lung Epithelial Cells through Harnessing the Innate Immune Response. International Journal of Molecular Sciences, 25(10), 5318.
https://doi.org/10.3390/ijms25105318